Wayne C. Cantwell Sells 15,000 Shares of Arteris, Inc. (NASDAQ:AIP) Stock

Arteris, Inc. (NASDAQ:AIP) Director Wayne C. Cantwell sold 15,000 shares of the firm’s stock in a transaction that occurred on Friday, September 6th. The shares were sold at an average price of $6.95, for a total transaction of $104,250.00. Following the transaction, the director now directly owns 243,198 shares in the company, valued at approximately $1,690,226.10. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.

Arteris Stock Performance

AIP traded up $0.10 during trading on Tuesday, hitting $6.95. The stock had a trading volume of 149,970 shares, compared to its average volume of 181,523. The firm has a market cap of $272.86 million, a PE ratio of -6.62 and a beta of 1.12. The company has a current ratio of 1.14, a quick ratio of 1.14 and a debt-to-equity ratio of 0.17. Arteris, Inc. has a 12 month low of $4.20 and a 12 month high of $9.54. The company has a 50 day simple moving average of $7.85 and a 200-day simple moving average of $7.58.

Arteris (NASDAQ:AIP) last posted its quarterly earnings data on Thursday, August 1st. The company reported ($0.21) EPS for the quarter, missing analysts’ consensus estimates of ($0.14) by ($0.07). Arteris had a negative return on equity of 274.66% and a negative net margin of 68.37%. The business had revenue of $14.58 million during the quarter, compared to the consensus estimate of $13.68 million. During the same quarter in the previous year, the firm posted ($0.25) earnings per share. Analysts expect that Arteris, Inc. will post -0.9 EPS for the current year.

Analysts Set New Price Targets

A number of research firms have recently weighed in on AIP. Rosenblatt Securities restated a “buy” rating and set a $15.00 price target on shares of Arteris in a report on Monday, August 5th. Westpark Capital reissued a “buy” rating and set a $11.00 price objective on shares of Arteris in a report on Wednesday, July 31st. Finally, Jefferies Financial Group restated a “hold” rating and issued a $9.00 target price (down from $11.00) on shares of Arteris in a report on Monday, May 13th.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the business. Algert Global LLC acquired a new stake in Arteris in the 2nd quarter worth $115,000. The Manufacturers Life Insurance Company bought a new stake in shares of Arteris in the second quarter valued at about $86,000. CloudAlpha Capital Management Limited Hong Kong bought a new stake in shares of Arteris in the second quarter valued at about $554,000. Renaissance Technologies LLC grew its position in Arteris by 6.1% during the second quarter. Renaissance Technologies LLC now owns 114,700 shares of the company’s stock worth $861,000 after buying an additional 6,600 shares in the last quarter. Finally, Rhumbline Advisers increased its stake in Arteris by 2,182.8% during the second quarter. Rhumbline Advisers now owns 31,822 shares of the company’s stock valued at $239,000 after acquiring an additional 30,428 shares during the period. 64.36% of the stock is owned by institutional investors.

Arteris Company Profile

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.